Genmab — Juli 2024
-
J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer https://www.fiercepharma.com/pharma/jjs-car-t-partner-legend-biotech-reportedly-receives-buyout-offer
-
Amgen, BMS and Merck have the most exposure as Big Pharma eyes $183B patent cliff: analyst https://www.fiercepharma.com/pharma/firepower-aplenty-and-patent-cliffs-ahead-time-right-ma-activity-report
-
Det er helt normalt med et tilbagefald (pull-back) efter en stigning på næsten 10%. Man kan se tidligere stigninger på dagkortet, hvor der altid har været tilbagefald. Jeg satser stadig på, at juli bliver en god måned. Tesla, Ennogie, amerikanske obligationer og bitcoin har oplevet pæne stigninger de seneste par uger. Jeg tror, at denne positive udvikling fortsætter i de nævnte positioner, herunder Genmab, resten af året. Mit bud p.t at der er nævnte positioner vil outperforme sp500 og nasdaq
-
Richter’s Transformation: Non-Chemo Options https://www.patientpower.info/chronic-lymphocytic-leukemia/richters-transformation-non-chemo-options
-
Du er en optimistisk mand @StockBull…..vi nærmer os med hastige skridt….
-
Genmab-investorerne kigger onsdag over middag mod USA, hvor samarbejdspartneren Johnson & Johnson er aktuel med sit regnskab for andet kvartal, hvilket også giver salgstal for den storsælgende kræftbehandling Darzalex. Genmab har udviklet Darzalex, som bruges til behandling mod knoglemarvskræft, mens Johnson & Johnson har markedsføringsrettighederne og betaler salgsprovision til Genmab. Biotekselskabet venter, at Darzalex-salget i 2024 når 10,9-11,5 mia. dollar.
-
Ja det er jeg Vitus men har heller ikke alle æg i en kurs. Hentet 11% de sidste 2 uger dage så det går nok.
https://proinvestor.com/boards/121167/$/121338 -
For Darzalex, the consensus mark is pegged at $2.89 billion, while our model estimates sales of $2.97 billion. https://www.nasdaq.com/articles/jj-jnj-stock-q2-earnings-buy-or-not-buy - that would be a very good number, can't believe we get there...
-
Teclistamab approved for people at fourth line and beyond on the NHS https://www.myeloma.org.uk/news/teclistamab-approved-for-people-at-fourth-line-and-beyond-on-the-nhs/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind